Switch to: Citations

Add references

You must login to add references.
  1. Paying research subjects: participants' perspectives.M. L. Russell - 2000 - Journal of Medical Ethics 26 (2):126-130.
    Objective—To explore the opinions of unpaid healthy volunteers on the payment of research subjects.Design—Prospective cohort.Setting—Southern Alberta, Canada.Participants—Medically eligible persons responding to recruiting advertisements for a randomised vaccine trial were invited to take part in a study of informed consent at the point at which they formally consented or refused trial participation. Of 72 invited, 67 returned questionnaires at baseline and 54 at follow-up.Outcome measures—Proportions of persons who agreed or disagreed with three close-ended statements on the payment of research subjects; themes (...)
    Download  
     
    Export citation  
     
    Bookmark   13 citations  
  • The influence of risk and monetary payment on the research participation decision making process.J. P. Bentley - 2004 - Journal of Medical Ethics 30 (3):293-298.
    Objectives: To determine the effects of risk and payment on subjects’ willingness to participate, and to examine how payment influences subjects’ potential behaviours and risk evaluations.Methods: A 3 × 3 , between subjects, completely randomised factorial design was used. Students enrolled at one of five US pharmacy schools read a recruitment notice and informed consent form for a hypothetical study, and completed a questionnaire. Risk level was manipulated using recruitment notices and informed consent documents from hypothetical biomedical research projects. Payment (...)
    Download  
     
    Export citation  
     
    Bookmark   46 citations  
  • Review of Ruth R. Faden and Tom L. Beauchamp: A History and Theory of Informed Consent[REVIEW]William G. Bartholome - 1988 - Ethics 98 (3):605-606.
    Download  
     
    Export citation  
     
    Bookmark   421 citations  
  • Money and Distorted Ethical Judgments about Research: Ethical Assessment of the TeGenero TGN1412 Trial. [REVIEW]Ezekiel J. Emanuel & Franklin G. Miller - 2007 - American Journal of Bioethics 7 (2):76-81.
    The recent TeGenero phase I trial of a novel monoclonal antibody in healthy volunteers produced a drastic inflammatory reaction in participants receiving the experimental agent. Commentators on the ethics of the research have focused considerable attention on the role of financial considerations: the for-profit status of the biotechnology company and Contract Research Organization responsible respectively for sponsoring and conducting the trial and the amount of monetary compensation to participants. We argue that these financial considerations are largely irrelevant and distort ethical (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations